查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541265

2024-2032 年按产品、应用、最终用途和地区分類的氧气治疗市场报告

Oxygen Therapy Market Report by Product, Application, End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2023年全球氧疗市场规模达189IMARC Group美元。慢性阻塞性肺病、气喘、间质性肺病和肺炎等呼吸系统疾病的盛行率不断上升，家庭医疗保健的需求不断增长，因为与住院治疗相比，家庭医疗保健更具成本效益，以及全球人口老化的加剧是推动该市场的一些主要因素。

氧气治疗市场分析：

主要市场驱动因素：气喘、慢性阻塞性肺病、间质性肺病和肺炎等疾病正在增加，刺激了对氧气治疗的需求。这加上老年人口的增加，是刺激氧气治疗市场成长的关键因素之一。

主要市场趋势：家庭医疗保健是呼吸系统疾病患者的新趋势，因为它为患者提供了便利。住院费用昂贵，而家庭医疗保健有助于省钱，这使得它非常受欢迎。

地理趋势：由于吸烟和环境污染导致呼吸道疾病盛行率上升，北美引领市场。然而，随着亚太地区老年人口的不断增加，该地区正在成为氧气治疗的新兴市场。

竞争格局：氧气治疗产业的一些主要市场参与者包括 Allied Healthcare Products Inc.、Becton Dickinson and Company、DeVilbiss Healthcare LLC (Drive Medical Inc.)、Fisher & Paykel Healthcare Limited、通用电气公司、Getinge AB、Hersill SL、 Invacare Corporation、Koninklijke Philips NV、Smiths Group plc、Tecno-Gaz SpA、Teleflex Incorporated 等。

挑战与机会：虽然市场面临一些挑战，例如某些地区的医疗保健服务有限，但它也遇到了远距医疗整合和远端监控功能等技术进步的机会。

氧气治疗市场趋势：

家庭医疗保健趋势

IMARC 集团的报告显示，2023 年全球家庭医疗保健市场规模将达到3,922 亿美元。环境。这种倾向正在推动对居家氧气治疗选择的需求。家庭医疗保健通常比住院护理更便宜，可以减少住院时间和相关费用。家庭医疗设备重量轻、使用简单，并允许患者保持活动能力和自由度，使家庭氧气治疗更加可行和有吸引力。许多慢性呼吸系统疾病，包括慢性阻塞性肺病和肺纤维化，需要长期吸氧治疗。家庭医疗保健可以对各种疾病进行持续、一致的管理，从而提高患者对治疗和结果的依从性。

呼吸道疾病的盛行率不断增加

根据世界卫生组织（WHO）网站2023年发表的文章，全球第三大死因是慢性阻塞性肺病（COPD），2019年造成323万人死亡。常见，需要氧气治疗来控制这些疾病的症状。由于呼吸系统疾病会产生有害影响，只有长期治疗才能帮助患者治疗这些疾病，因此氧气治疗对于维持血液中足够的氧气水平，同时控制慢性呼吸系统疾病非常有价值。

人口老化

老年人更容易患有慢性阻塞性肺病、肺气肿和肺炎等呼吸道疾病，氧气治疗是治疗这些疾病的唯一方法。老年人可能患有多种慢性疾病，如高血压、心臟病、糖尿病，这些疾病会加重呼吸道疾病，刺激对氧气治疗的需求。老年人的免疫系统较弱，可能会吸引多种感染，进而导致严重的呼吸道疾病。国际货币基金组织（IMF）电子图书馆网站上发表的一篇文章显示，到2050年，全球80岁及以上人口的比例预计将翻两番，达到近5%。

氧疗市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品、应用和最终用途对市场进行了分类。

按产品划分：

氧源设备

氧气瓶

制氧机

液态氧装置

气道通气设备

氧气输送装置

氧气面罩

鼻插管

文丘里面罩

非循环呼吸面罩

袋阀口罩

持续性呼吸道正压通气面罩

其他的

氧源设备占据大部分市场份额

该报告根据产品提供了详细的市场细分和分析。这包括氧源设备（氧气瓶、氧气浓缩器、液态氧设备和 PAP 设备）和氧气输送设备（氧气面罩、鼻插管、文丘里面罩、非循环呼吸面罩、袋阀面罩、CPAP 面罩等）。报告称，氧源设备是最大的细分市场。

氧源设备对于氧气治疗至关重要，因为它为患者提供所需的氧气。如果没有这些设备，就很难为有需要的患者提供氧气，这使得它们成为市场的必需品。这些设备可用于多种环境，包括医院、诊所和家庭医疗保健设施。他们在许多医疗保健环境中的适应性和要求推动了他们的强劲需求。氧源设备的不断进步和改进，例如便携式和轻型设计、更高的效率和用户友好的功能，正在影响氧气治疗市场的概况。

按应用划分：

慢性阻塞性肺臟疾病

气喘

阻塞性睡眠呼吸中止症

呼吸窘迫症候群

囊肿纤维化

肺炎

其他的

慢性阻塞性肺病占业界最大份额

报告还提供了基于应用程式的详细市场细分和分析。这包括慢性阻塞性肺病、气喘、阻塞性睡眠呼吸中止症、呼吸窘迫症候群、囊性纤维化、肺炎等。报告称，慢性阻塞性肺病占据最大的市场份额。

COPD的高发生率直接对应于需要氧疗的大量患者群体，使其成为最常见的应用领域。慢性阻塞性肺病是一种进行性慢性疾病，通常会随着时间的推移而恶化，需要长期照护和治疗。慢性阻塞性肺病患者可能需要持续或间歇性氧气治疗来控制症状并维持生活品质。氧气治疗可缓解呼吸困难和严重呼吸短促，使其成为慢性阻塞性肺病管理的重要组成部分，从而对氧气治疗市场产生积极影响。

按最终用途细分：

家庭医疗保健

医院

家庭医疗保健代表了领先的细分市场

该报告根据最终用途提供了详细的市场细分和分析。这包括家庭医疗保健和医院。根据该报告，家庭医疗保健是最大的细分市场。

患者喜欢在自己舒适的家中而不是在医院或诊所接受护理。家庭医疗保健使患者能够继续他们的习惯并留在熟悉的环境中，这可以提高他们的整体生活品质和护理满意度。一般来说，家庭医疗保健的费用低于住院治疗。无需长时间住院，降低医疗费用，减轻医疗机构的压力。这种成本效益对患者和医疗保健专业人员都有吸引力。医疗技术的进步，特别是便携式製氧机和其他家用氧气输送系统的进步，简化了患者在家中接受氧气治疗的过程。这些小工具变得更加用户友好、高效和便携，增加了它们对家庭使用的吸引力。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美市场领先，占据最大的氧气治疗市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是氧疗最大的区域市场。

北美地区慢性阻塞性肺病、气喘和睡眠呼吸中止症等呼吸系统疾病的盛行率很高，这些疾病是由人口老化、吸烟和环境污染等因素引起的。先进的医疗基础设施、尖端医疗技术的广泛应用以及可靠的医疗报销法规都有助于推动市场向前发展。此外，家庭医疗保健的日益普及以及便携式和用户友好的氧气治疗设备的出现使患者可以更轻鬆地在家中管理自己的疾病。此外，该地区的主要参与者正致力于扩大氧气等气体的储存能力。例如，查特工业公司于 2024 年宣布其位于阿拉巴马州西奥多的大型低温储槽製造工厂盛大开幕。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。氧疗行业的一些主要市场参与者包括 Allied Healthcare Products Inc.、Becton Dickinson and Company、DeVilbiss Healthcare LLC (Drive Medical Inc.)、Fisher & Paykel Healthcare Limited、通用电气公司、Getinge AB、Hersill SL、Invacare Corporation、 Koninklijke Philips NV、Smiths Group plc、Tecno-Gaz SpA、Teleflex Incorporated 等。

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

氧气处理市场的主要公司积极参与各种策略活动，旨在扩大市场占有率、改善产品供应并满足不断变化的客户需求。氧疗市场领导者正在投资研发 (R&D) 活动，以生产具有先进功能、改进便携性和提高效率的革命性氧气治疗设备。此外，重要企业经常利用併购 (M&A) 和联盟来扩大其产品组合、扩大其地理覆盖范围并进入新市场。例如，查特工业公司（Chart Industries, Inc.）是工业气体、特种和能源转型市场工艺技术和设备工程和製造领域的全球领导者，完成了对豪顿（Howden）的收购，豪顿是关键任务空气和气体处理产品的全球领先供应商，服务，由KPS Capital Partners, LP (“KPS”) 的附属公司于2023 年提供。优势的知识。

氧疗市场新闻：

2023 年 7 月：艾默生推出了 ASCO™ 系列 588 固定式製氧机歧管，这是医疗保健行业首个交钥匙歧管解决方案，旨在优化呼吸治疗设备设计并加快产品上市速度。

本报告回答的关键问题

  • 全球氧气治疗市场有多大
  • 2024-2032年全球氧气治疗市场的预期成长率是多少
  • 推动全球氧气治疗市场的关键因素是什么
  • COVID-19 对全球氧气治疗市场有何影响
  • 基于产品的全球氧气治疗市场的细分是什么
  • 根据应用，全球氧气治疗市场的细分如何
  • 根据最终用途，全球氧气治疗市场的细分情况如何
  • 全球氧气治疗市场的重点区域有哪些
  • 谁是全球氧气治疗市场的主要参与者/公司

本报告回答的关键问题

  • 全球氧气治疗市场有多大？ 2024-2032年全球氧气治疗市场的预期成长率是多少？
  • 推动全球氧气治疗市场的关键因素是什么？
  • COVID-19 对全球氧气治疗市场有何影响？
  • 基于该产品的全球氧疗市场的细分情况如何？
  • 根据应用，全球氧气治疗市场的细分情况如何？
  • 根据最终用途，全球氧气治疗市场的细分情况如何？
  • 全球氧气治疗市场的重点区域有哪些？
  • 全球氧气治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球氧气治疗市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 氧源设备
    • 市场趋势
    • 关键环节
      • 氧气瓶
      • 制氧机
      • 液态氧装置
      • 气道通气设备
    • 市场预测
  • 氧气输送装置
    • 市场趋势
    • 关键环节
      • 氧气面罩
      • 鼻插管
      • 文丘里面罩
      • 非循环呼吸面罩
      • 袋阀口罩
      • 持续性呼吸道正压通气面罩
      • 其他的
    • 市场预测

第 7 章：市场区隔：按应用

  • 慢性阻塞性肺臟疾病
    • 市场趋势
    • 市场预测
  • 气喘
    • 市场趋势
    • 市场预测
  • 阻塞性睡眠呼吸中止症
    • 市场趋势
    • 市场预测
  • 呼吸窘迫症候群
    • 市场趋势
    • 市场预测
  • 囊肿纤维化
    • 市场趋势
    • 市场预测
  • 肺炎
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：最终用途别

  • 家庭医疗保健
    • 市场趋势
    • 市场预测
  • 医院
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Allied Healthcare Products Inc.
    • Becton Dickinson and Company
    • DeVilbiss Healthcare LLC (Drive Medical Inc.)
    • Fisher & Paykel Healthcare Limited
    • General Electric Company
    • Getinge AB
    • Hersill SL
    • Invacare Corporation
    • Koninklijke Philips NV
    • Smiths Group plc
    • Tecno-Gaz SpA
    • Teleflex Incorporated
Product Code: SR112024A3847

The global oxygen therapy market size reached US$ 18.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032. The growing prevalence of respiratory diseases like COPD, asthma, interstitial lung disease, and pneumonia, rising need for home healthcare as it is more cost-effective compared to inpatient care, and increasing aging population worldwide are some of the major factors driving the market.

Oxygen Therapy Market Analysis:

Major Market Drivers: Diseases like asthma, COPD, interstitial lung disease, and pneumonia are increasing, which is catalyzing the demand for oxygen therapy. This, along with the rising geriatric population, represents one of the key factors stimulating the oxygen therapy market growth.

Key Market Trends: Home healthcare is the new trend among people suffering from respiratory diseases, as it provides convenience to patients. Hospitals stays are costly, and home healthcare helping in saving money, which makes it highly preferable.

Geographical Trends: North America leads the market because of rising prevalence of respiratory diseases owing to smoking and environmental pollution. However, as elderly population is increasing in the Asia Pacific region, this region is becoming an emerging market for oxygen therapy.

Competitive Landscape: Some of the major market players in the oxygen therapy industry include Allied Healthcare Products Inc., Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive Medical Inc.), Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Hersill SL, Invacare Corporation, Koninklijke Philips N.V, Smiths Group plc, Tecno-Gaz S.p.A.,Teleflex Incorporated, among many others.

Challenges and Opportunities: While the market faces challenges, such as limited healthcare access in several regions, it also encounters opportunities in technological advancements like telemedicine integration and remote monitoring capabilities.

Oxygen Therapy Market Trends:

Home Healthcare Trends

The IMARC Group's report shows that the global home healthcare market reached US$ 392.2 Billion in 2023. Many patients, particularly among the elderly and those with chronic diseases, prefer the comfort and convenience of receiving care at home over institutional settings, such as hospitals or nursing homes. This inclination is driving the demand for home oxygen therapy options. Home healthcare is frequently more affordable than inpatient care, lowering hospital stays and associated costs. Home healthcare devices are lightweight, simple to use, and allow patients to preserve their mobility and freedom, making home oxygen therapy more viable and appealing. Many chronic respiratory disorders, including COPD and pulmonary fibrosis, necessitate long-term oxygen treatment. Home healthcare allows for ongoing and consistent management of various illnesses, which improves patient adherence to treatment and outcomes.

Increasing Prevalence of Respiratory Diseases

According to an article published on the website of the World Health Organization (WHO) in 2023, the third leading cause of death worldwide is chronic obstructive pulmonary disease (COPD), causing 3.23 million deaths in 2019. COPD, asthma, interstitial lung disease, and pneumonia is very common and there is a requirement of oxygen therapy for managing the symptoms of these diseases. Because respiratory diseases have harmful impact and only long-term management can help patients treat these conditions, oxygen therapy is highly valuable in maintaining adequate levels of oxygen in the blood while managing chronic respiratory conditions.

Aging Population

Elderly people are more susceptible to respiratory conditions like COPD, emphysema, and pneumonia, and oxygen therapy is the only way to manage these conditions. Old people may have several chronic conditions, such as hypertension, heart disease, diabetes, which can worsen respiratory problems, thereby catalyzing the demand for oxygen therapy. The weak immune system of the geriatric population can attract several infections, which can lead to severe respiratory diseases. An article published on the website of the International Monetary Fund (IMF) eLibrary shows that by 2050 the global share of people aged 80 and older is expected to quadruple to almost 5%.

Oxygen Therapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and end use.

Breakup by Product:

Oxygen Source Equipment

Oxygen Cylinders

Oxygen Concentrators

Liquid Oxygen Devices

PAP Devices

Oxygen Delivery Devices

Oxygen Masks

Nasal Cannula

Venturi Masks

Non-rebreather Masks

Bag Valve Masks

CPAP Masks

Others

Oxygen source equipment accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes oxygen source equipment (oxygen cylinders, oxygen concentrators, liquid oxygen devices, and PAP devices) and oxygen delivery devices (oxygen masks, nasal cannula, venturi masks, non-rebreather masks, bag valve masks, CPAP masks, and others). According to the report, oxygen source equipment represents the largest segment.

Oxygen source equipment is essential for oxygen treatment because it supplies patients with the oxygen they require. Without these devices, it would be hard to provide oxygen to patients in need, making them market essential. These devices are utilized in a variety of contexts, including hospitals, clinics, and home healthcare facilities. Their adaptability and requirement in many healthcare settings are driving their strong demand. Continuous advancements and improvements in oxygen source equipment, such as portable and lightweight designs, better efficiency, and user-friendly features, are influencing the oxygen therapy market overview.

Breakup by Application:

Chronic Obstructive Pulmonary Disease

Asthma

Obstructive Sleep Apnea

Respiratory Distress Syndrome

Cystic Fibrosis

Pneumonia

Others

Chronic obstructive pulmonary disease holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, cystic fibrosis, pneumonia, and others. According to the report, chronic obstructive pulmonary disease accounts for the largest market share.

The high incidence of COPD directly corresponds to a large patient population requiring oxygen therapy, making it the most common application area. COPD is a progressive and chronic ailment that usually worsens with time, demanding long-term care and treatment. Patients with COPD may require continuous or intermittent oxygen therapy to control symptoms and maintain their quality of life. Oxygen treatment alleviates respiratory difficulties and severe shortness of breath, making it an essential part of COPD management, thereby positively influencing the oxygen therapy market insights.

Breakup by End Use:

Home Healthcare

Hospitals

Home healthcare represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end use. This includes home healthcare and hospitals. According to the report, home healthcare represents the largest segment.

Patients prefer to receive care in the comfort of their own homes rather than in hospitals or clinics. Home healthcare enables patients to continue their habits and remain in familiar settings, which can improve their overall quality of life and satisfaction with care. In general, home healthcare costs less than inpatient treatment. It eliminates the need for prolonged hospital stays, lowers healthcare expenses, and eases the pressure on healthcare institutions. This cost-effectiveness appeals to both patients and healthcare professionals. Medical technology advancements, particularly in portable oxygen concentrators and other home-use oxygen delivery systems, have simplified patients' access to oxygen therapy at home. These gadgets have become more user-friendly, efficient, and portable, increasing their attractiveness for home use.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest oxygen therapy market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for oxygen therapy.

North America has a high prevalence of respiratory disorders like COPD, asthma, and sleep apnea, which are caused by factors, such as aging populations, smoking, and environmental pollution. Advanced healthcare infrastructure, widespread availability of cutting-edge medical technologies, and solid healthcare reimbursement regulations all help to drive the market forward. Furthermore, the increasing popularity of home healthcare and the availability of portable and user-friendly oxygen therapy devices make it easier for patients to manage their diseases at home. Moreover, key players operating in this region are focusing on expanding their storage capacities of gases like oxygen. For instance, in 2024 Chart Industries announced the grand opening of its jumbo cryogenic tank manufacturing facility in Theodore, Alabama.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the oxygen therapy industry include Allied Healthcare Products Inc., Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive Medical Inc.), Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Hersill SL, Invacare Corporation, Koninklijke Philips N.V, Smiths Group plc, Tecno-Gaz S.p.A.,Teleflex Incorporated, etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key companies in the oxygen treatment market are actively involved in a variety of strategic activities aimed at increasing their market presence, improving product offerings, and fulfilling changing customer needs. Oxygen therapy market leaders are investing in research and development (R&D) activities to produce revolutionary oxygen therapy equipment with advanced features, improved portability, and increased efficiency. Furthermore, significant businesses frequently use mergers and acquisitions (M&A), and alliances to boost their product portfolios, expand their geographic reach, and enter new markets. For instance, Chart Industries, Inc., a global leader in engineering and manufacturing of process technology and equipment for industrial gas, specialty and energy transition markets, completed its acquisition of Howden, a leading global provider of mission critical air and gas handling products and services, from affiliates of KPS Capital Partners, LP ("KPS") in 2023. Some businesses are also engaging in marketing and educational initiatives to improve knowledge about respiratory health and the advantages of oxygen treatment.

Oxygen Therapy Market News:

July 2023: Emerson has launched the ASCO(TM) Series 588 Stationary Oxygen Concentrator Manifold, the healthcare industry's first turnkey manifold solution designed to optimize respiratory therapy device designs and accelerate product speed to market.

Key Questions Answered in This Report

  • 1. How big is the global oxygen therapy market?
  • 2. What is the expected growth rate of the global oxygen therapy market during 2024-2032?
  • 3. What are the key factors driving the global oxygen therapy market?
  • 4. What has been the impact of COVID-19 on the global oxygen therapy market?
  • 5. What is the breakup of the global oxygen therapy market based on the product?
  • 6. What is the breakup of the global oxygen therapy market based on the application?
  • 7. What is the breakup of the global oxygen therapy market based on the end use?
  • 8. What are the key regions in the global oxygen therapy market?
  • 9. Who are the key players/companies in the global oxygen therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oxygen Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oxygen Source Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Oxygen Cylinders
      • 6.1.2.2 Oxygen Concentrators
      • 6.1.2.3 Liquid Oxygen Devices
      • 6.1.2.4 PAP Devices
    • 6.1.3 Market Forecast
  • 6.2 Oxygen Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Oxygen Masks
      • 6.2.2.2 Nasal Cannula
      • 6.2.2.3 Venturi Masks
      • 6.2.2.4 Non-rebreather Masks
      • 6.2.2.5 Bag Valve Masks
      • 6.2.2.6 CPAP Masks
      • 6.2.2.7 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Chronic Obstructive Pulmonary Disease
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Obstructive Sleep Apnea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Respiratory Distress Syndrome
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cystic Fibrosis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Pneumonia
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Home Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allied Healthcare Products Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DeVilbiss Healthcare LLC (Drive Medical Inc.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fisher & Paykel Healthcare Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 General Electric Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Getinge AB
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Hersill SL
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Invacare Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Smiths Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Tecno-Gaz S.p.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Teleflex Incorporated
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Oxygen Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Oxygen Therapy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Oxygen Therapy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Oxygen Therapy Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Oxygen Therapy Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Oxygen Therapy Market: Breakup by End Use (in %), 2023
  • Figure 7: Global: Oxygen Therapy Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Oxygen Therapy (Oxygen Source Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Oxygen Therapy (Oxygen Source Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Oxygen Therapy (Oxygen Delivery Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Oxygen Therapy (Oxygen Delivery Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Oxygen Therapy (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Oxygen Therapy (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Oxygen Therapy (Cystic Fibrosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Oxygen Therapy (Cystic Fibrosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Oxygen Therapy (Pneumonia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Oxygen Therapy (Pneumonia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Oxygen Therapy (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Oxygen Therapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Oxygen Therapy (Home Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Oxygen Therapy (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Oxygen Therapy (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Oxygen Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Oxygen Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Oxygen Therapy Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Oxygen Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Oxygen Therapy Industry: SWOT Analysis
  • Figure 80: Global: Oxygen Therapy Industry: Value Chain Analysis
  • Figure 81: Global: Oxygen Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oxygen Therapy Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Oxygen Therapy Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Oxygen Therapy Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Oxygen Therapy Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Oxygen Therapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Oxygen Therapy Market: Competitive Structure
  • Table 7: Global: Oxygen Therapy Market: Key Players